%0 Journal Article
%A Galldiks, Norbert
%A Verger, Antoine
%A Zaragori, Timothée
%A Unterrainer, Marcus
%A Suchorska, Bogdana
%A Lohman, Philipp
%A Tonn, Jörg C
%A Langen, Karl-Josef
%A Albert, Nathalie L
%T Comment on “Hypometabolic gliomas on FET-PET - Is there an inverted U-curve for survival?”, Kamson 2019, Neuro-Oncology
%J Neuro-Oncology
%V 21
%N 12
%@ 1523-5866
%C Oxford
%I Oxford Univ. Press
%M FZJ-2019-04730
%P 1612-1613
%D 2019
%X With great interest we read the editorial by Kamson entitled “Hypometabolic Gliomas on FET-PET—Is There an Inverted U-Curve for Survival?” in Neuro-Oncology1 referring to our publication regarding the clinical relevance of photopenic defects on O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in glioma patients.2 In that paper, we identified within 100 patients with FET-PET–negative gliomas a subgroup of patients who even exhibit photopenic defects and had, moreover, an unfavorable outcome compared with gliomas with indifferent FET uptake (isometabolic gliomas). From our point of view, the frequency of photopenic defects is even lower than 10% (ie, ~5%). In his editorial, the author raised valuable new thoughts and ideas that are worth discussing.
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:31504819
%U <Go to ISI:>//WOS:000509393300018
%R 10.1093/neuonc/noz173
%U https://juser.fz-juelich.de/record/865194